Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
---|---|---|---|---|---|---|---|---|
2024-01-16 | Adaptimmune Therapeutics PLC | Rawcliffe Adrian
(Chief Executive Officer) |
S | American Depositary Shares representing Ordinary Shares | D | 39384 | $0.67 - $0.79 | $27,593 |
2024-01-16 | Adaptimmune Therapeutics PLC | Norry Elliot
(Chief Medical Officer) |
S | American Depositary Shares representing Ordinary Shares | D | 20563 | $0.67 - $0.79 | $14,104 |
2024-01-16 | Adaptimmune Therapeutics PLC | Lunger John
(Chief Patient Supply Officer) |
S | American Depositary Shares representing Ordinary Shares | D | 22795 | $0.67 - $0.79 | $15,886 |
2024-01-16 | Adaptimmune Therapeutics PLC | Bertrand William ...
(Chief Operating Officer) |
S | American Depositary Shares representing Ordinary Shares | D | 23589 | $0.67 - $0.79 | $16,421 |
2024-01-11 | Adaptimmune Therapeutics PLC | Norry Elliot
(Chief Medical Officer) |
S | American Depositary Shares representing Ordinary Shares | D | 11808 | $0.84 - $0.85 | $10,015 |
2024-01-11 | Adaptimmune Therapeutics PLC | Bertrand William ...
(Chief Operating Officer) |
S | American Depositary Shares representing Ordinary Shares | D | 9229 | $0.84 - $0.85 | $7,812 |
2024-01-11 | Adaptimmune Therapeutics PLC | Rawcliffe Adrian
(Chief Executive Officer) |
S | American Depositary Shares representing Ordinary Shares | D | 29202 | $0.84 - $0.85 | $24,733 |
2024-01-11 | Adaptimmune Therapeutics PLC | Lunger John
(Chief Patient Supply Officer) |
S | American Depositary Shares representing Ordinary Shares | D | 9229 | $0.84 - $0.85 | $7,812 |
A | Grant, award or other acquisition |
C | Conversion of Derivative or Security |
D | Disposition to the issuer of issuer equity securities |
E | Expiration of short derivative position |
F | Payment of exercise price or tax liability |
G | Bona fide Gift |
H | Expiration (or cancellation) of long derivative position with value received |
I | Discretionary Transaction |
J | Other acquisition or disposition |
K | Transaction in equity swap or instrument with similar characteristics |
L | Small Acquisition |
M | Exercise or conversion of derivative security |
O | Exercise of out-of-the-money derivative security |
P | Open Market Purchase |
S | Open Market Sale |
U | Disposition pursuant to a tender of shares in a change of control transaction |
V | Transaction Voluntarily Reported |
X | Exercise of in-the-money or at-the-money derivative security |
Z | Deposit into or withdrawal from voting trust |